Stergios Moschos, MD
UNC Lineberger Comprehensive Cancer Center · University of North Carolina, Chapel Hill · Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stergios Moschos, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07740941 · NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) MelanomaUNC Lineberger Comprehensive Cancer Center · recruiting · Melanoma (Skin Cancer), Melanoma Stage Stage IIIB, Melanoma Stage M1 · principal investigator
- Ph2NCT03765229 · An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV MelanomaUNC Lineberger Comprehensive Cancer Center · completed · Melanoma · principal investigator
- Ph2NCT03620019 · Denosumab + PD-1 in Subjects With Stage III/ IV MelanomaUNC Lineberger Comprehensive Cancer Center · completed · Melanoma Stage Iii, Melanoma Stage Iv, Melanoma · principal investigator
- Ph1NCT03454035 · Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsUNC Lineberger Comprehensive Cancer Center · recruiting · Tumor, Solid, Pancreatic Cancer, Melanoma · principal investigator
- Ph2NCT03089606 · Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging BiomarkerUNC Lineberger Comprehensive Cancer Center · completed · Melanoma · principal investigator
- N/ANCT01312506 · Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and ControlsUniversity of Pittsburgh · withdrawn · Metastatic Melanoma, CNS Metastases · principal investigator
- Ph1NCT00111696 · Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant MelanomaMedImmune LLC · completed · Malignant Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.